GeoVax Labs Announces Warrant Exercise, Raises ~$3.65M and Issues New Warrants

What Happened

• On August 25, 2026 GeoVax Labs, Inc. entered an inducement letter with a holder of existing warrants. The holder exercised an aggregate of 5,697,628 warrants for cash, and the Company received approximately $3,646,482 in gross proceeds.
• In exchange, the Company issued new warrants on August 26, 2026 to purchase up to 11,395,256 shares of common stock at an exercise price of $0.64 per share. The New Warrants expire five years after issuance and are substantially identical to the exercised warrants.
• GeoVax engaged A.G.P./Alliance Global Partners as exclusive financial advisor and will pay AGP a cash fee equal to 7.0% of the gross proceeds and reimburse up to $40,000 in legal expenses. The Company expects to use net proceeds for general corporate purposes.

Key Details

• Exercised warrants purchased: 5,697,628 shares; gross cash proceeds: ~$3,646,482 (before fees/expenses).
• New Warrants cover up to 11,395,256 shares at $0.64 per share; exercisable after any required Nasdaq stockholder approvals; five-year term.
• Company will file a resale registration statement for the New Warrant Shares within 30 days and agreed to keep it effective until no New Warrants/New Warrant Shares remain.
• Company agreed to hold an annual or special meeting on or before October 29, 2026 to obtain required stockholder approval.

Why It Matters

• This transaction raises immediate cash (~$3.65M) for GeoVax’s general corporate needs while creating the potential for future dilution if the new warrants are exercised (up to 11.4M shares).
• The registration and planned stockholder meeting are needed to enable holders to resell shares issued on exercise and to finalize the exerciseability of the New Warrants; until those steps are completed, exercise and resale may be restricted.
• Investors should note the advisory fee (7% of proceeds) and legal reimbursements reduce net proceeds, and the issuance of a large block of warrants represents a possible overhang on the share count if exercised.